Please try another search
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; information technology services; and pharmaceutical science and technology development activities, as well as sale, wholesale, and retail of drugs. In addition, it is involved in the manufacture, development, and sale of medicine raw materials and relevant products; manufacture of chemical products; and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
Name | Age | Since | Title |
---|---|---|---|
Da Zhang | 41 | 2018 | CFO, Senior VP & Executive Director |
Rui Yang | 44 | 2011 | Co-CEO & Executive Director |
Liang Hong | 49 | 2011 | Executive VP & Executive Director |
Hao Hong | 67 | 2011 | Founder, Chairman & CEO |
Xinxin Zhi | 43 | 2011 | Chairman of the Supervisory Committee |
Kar Chung Lee | 42 | 2021 | Independent Non Executive Director |
Ye Song | 63 | 2011 | Non-Executive Director |
Shanshan Di | 37 | 2017 | Shareholder representative Supervisor |
Jingyi Hou | 40 | 2021 | Employee Representative Supervisor |
Stephane Caron | - | - | Member of Scientific Advisory Board |
Scott May | - | - | Member of Scientific Advisory Board |
Timothy F. Jamison | - | - | Member of Scientific Advisory Board |
Ting Zhang | 38 | 2021 | Non-Executive Director |
Patricia Alred | - | - | Member of Scientific Advisory Board |
Jin-Quan Yu | - | - | Member of Scientific Advisory Board |
Nicholas Turner | - | - | Member of Scientific Advisory Board |
Martin Eastgate | - | - | Member of Scientific Advisory Board |
Seble Wagaw | - | - | Member of Scientific Advisory Board |
Stephen L. Buchwald | - | - | Member of Scientific Advisory Board |
Phil S. Baran | 47 | - | Member of Scientific Advisory Board |
Xuejiao Sun | 41 | 2023 | Independent Non-Executive Director |
Xinyi Hou | 62 | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review